Lista de obras -

"Maybe they have found something new" participants' views on returning cohort psychosocial survey results

artículo científico publicado en 2014

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

artículo científico publicado en 2011

A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results

artículo científico publicado en 2006

A six-gene signature predicting breast cancer lung metastasis.

artículo científico publicado en 2008

An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition

artículo científico publicado en 2011

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

artículo científico publicado en 2015

BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations

artículo científico publicado en 2003

BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis

artículo científico publicado en 2012

Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec

artículo científico publicado en 2011

Breast cancer risk inBRCA1 andBRCA2 mutation carriers and polyglutamine repeat length in theAIB1 gene

article

CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study

artículo científico publicado en 2013

Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations ⬇️

artículo científico publicado el 26 de enero de 2011

Cigarette smoking in women after BRCA1/2 genetic test disclosure: a 5-year follow-up study of the GENEPSO PS cohort

artículo científico publicado en 2014

Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers

scientific article published on 01 January 2005

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2011

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction

artículo científico publicado en 2010

Disclosure of research results: a randomized study on GENEPSO-PS cohort participants

artículo científico publicado en 2015

Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result

artículo científico publicado en 2016

Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers

artículo científico publicado en 2017

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).

artículo científico publicado en 2012

Familial breast cancer and DNA repair genes: insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing

article

GENESIS: a French national resource to study the missing heritability of breast cancer

artículo científico publicado en 2016

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2010

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

artículo científico publicado en 2013

Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)

artículo científico publicado en 2004

Impact of BRCA1/2 mutation on young women's 5-year parenthood rates: a prospective comparative study (GENEPSO-PS cohort).

artículo científico publicado en 2015

Is the psychological impact of genetic testing moderated by support and sharing of test results to family and friends?

artículo científico publicado en 2013

Life-threatening sepsis associated with adjuvant doxorubicin plus docetaxel for intermediate-risk breast cancer

artículo científico publicado en 2005

Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study

artículo científico publicado en 2016

Oncogenetic consultation for breast cancer

artículo científico publicado en 2007

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group

artículo científico publicado en 2007

Patients' characteristics and rate of Internet use to obtain cancer information

artículo científico publicado en 2006

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

artículo científico publicado en 2020

Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS)

artículo científico publicado en 2006

Psychometric properties of a French version of a Dutch scale for assessing breast and body image (BBIS) in healthy women

artículo científico publicado en 2013

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2017

Significant contribution of germline BRCA2 rearrangements in male breast cancer families

artículo científico publicado en 2004

Spontaneous disclosure of BRCA1/2 genetic test results to employers: a French prospective study ⬇️

artículo científico publicado el 29 de febrero de 2012

Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2013

Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2

artículo científico publicado en 2015

The supply of breast/ovarian cancer genetic susceptibility tests in France

artículo científico publicado en 2004

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).

artículo científico publicado en 2012

Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?

artículo científico publicado en 2013

Lista de obras de

"Maybe they have found something new" participants' views on returning cohort psychosocial survey results

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results

A six-gene signature predicting breast cancer lung metastasis.

An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations

BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis

Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec

Breast cancer risk inBRCA1 andBRCA2 mutation carriers and polyglutamine repeat length in theAIB1 gene

CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study

Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations ⬇️

Cigarette smoking in women after BRCA1/2 genetic test disclosure: a 5-year follow-up study of the GENEPSO PS cohort

Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction

Disclosure of research results: a randomized study on GENEPSO-PS cohort participants

Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result

Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).

Familial breast cancer and DNA repair genes: insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing

GENESIS: a French national resource to study the missing heritability of breast cancer

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)

Impact of BRCA1/2 mutation on young women's 5-year parenthood rates: a prospective comparative study (GENEPSO-PS cohort).

Is the psychological impact of genetic testing moderated by support and sharing of test results to family and friends?

Life-threatening sepsis associated with adjuvant doxorubicin plus docetaxel for intermediate-risk breast cancer

Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study

Oncogenetic consultation for breast cancer

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group

Patients' characteristics and rate of Internet use to obtain cancer information

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS)

Psychometric properties of a French version of a Dutch scale for assessing breast and body image (BBIS) in healthy women

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Significant contribution of germline BRCA2 rearrangements in male breast cancer families

Spontaneous disclosure of BRCA1/2 genetic test results to employers: a French prospective study ⬇️

Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2

The supply of breast/ovarian cancer genetic susceptibility tests in France

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).

Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?